Martha Arellano
0000-0003-1636-1962
4 papers found
Refreshing results…
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial
Lysine acetylation restricts mutant IDH2 activity to optimize transformation in AML cells
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)
How I treat older patients with acute myeloid leukemia: Treating Older Patients with AML
Missing publications? Search for publications with a matching author name.